Clinical Trial Update: An Open-Label Study to Evaluate the Efficacy of High-Dose Gammaplex in Children on the Autism Spectrum [Phase 4]

View source ↗

Summary

Open-label Phase 4 trial evaluating high-dose Gammaplex (IVIG) for efficacy in children with autism spectrum disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorder

Drugs mentioned

• GAMMAPLEX (intravenous immunoglobulin (IVIG))

Snippet

Sponsor: Isaac Melamed | Conditions: Autism, Autistic Disorder | Phase 4 | Status: UNKNOWN